Unicycive Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell UNCY and other ETFs, options, and stocks.About UNCY
Unicycive Therapeutics, Inc. is a biotechnology company, which engages in developing novel treatments for kidney diseases. The firm investigational treatment is oxylanthanum carbonate, a novel phosphate binding agent currently under review by the U.S.
UNCY Key Statistics
Stock Snapshot
With a market cap of 117.41M, Unicycive Therapeutics(UNCY) trades at $4.23. The stock has a price-to-earnings ratio of -2.64.
During the trading session on 2026-10-03, Unicycive Therapeutics(UNCY) shares reached a daily high of $4.67 and a low of $4.09. At a current price of $4.23, the stock is +3.4% higher than the low and still -9.4% under the high.
Trading activity shows a volume of 1.51M, compared to an average daily volume of 931.35K.
Over the past 52 weeks, Unicycive Therapeutics(UNCY) stock has traded between a high of $8.74 and a low of $3.93.
Over the past 52 weeks, Unicycive Therapeutics(UNCY) stock has traded between a high of $8.74 and a low of $3.93.
UNCY News
Unicycive Therapeutics ( (UNCY) ) has issued an announcement. On September 29, 2026, Unicycive Therapeutics announced it had resubmitted its New Drug Applicati...
Unicycive Therapeutics (UNCY) announced the resubmission of its New Drug Application, NDA, for oxylanthanum carbonate, OLC, the Company’s investigational oral p...
...
Analyst ratings
100%
of 10 ratingsMore UNCY News
The latest update is out from Unicycive Therapeutics ( (UNCY) ). On September 3, 2026, a securities class action lawsuit was filed in the United States Distric...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.